ivWatch, LLC

ivWatch, LLC ivWatch, LLC is medical device and biosensor company looking to improve patient safety during IV use

ivWatch, LLC is a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy. IV therapy is a basic yet critical component of care in hospital and outpatient settings, but it has a high failure rate. Continuous monitors exist to keep track of patients’ heart, blood oxygen levels and pulse rates. Until now, no technology has been available to continuously monitor the health of a patient’s IV site, and whether drugs or fluids are being delivered through the vein or leaking into the tissue. The ivWatch Model 400 is a FDA-cleared device to help clinicians monitor the status of a patient’s IV to aid in the early detection of peripheral IV infiltrations and extravasations. Through the use of non-invasive sensor technology, the ivWatch Model 400 can help reduce potentially serious medication dosing errors and associated patient harm from infiltration events. A continuously monitored peripheral IV also offers an alternative to more intrusive vascular access devices when medically indicated. Use of these devices has increased, but can also pose significant risk of harm to patients and greater cost and liability for hospitals. ivWatch has the potential to transform IV therapy by improving patient care and safety, and offering health care providers a much-needed, reliable and cost-effective solution for continuously monitoring peripheral IVs.

Powerful Clinical Evidence: Continuous IV Monitoring Reduces Severe NICU Injuries.In neonatal care, even the smallest IV...
12/30/2025

Powerful Clinical Evidence: Continuous IV Monitoring Reduces Severe NICU Injuries.

In neonatal care, even the smallest IV can cause serious problems. A new BMJ Open study highlights how early detection technology can help prevent serious peripheral IV infiltrations and extravasations (PIVIEs) in the most vulnerable patients.

PIVIEs are the most common neonatal IV complication and often develop silently, causing significant harm before they are noticed.

Roland Van Rens analyzed data from a major NICU in Doha, Qatar, where clinicians compared traditional “Touch, Look, Compare” checks with ivWatch continuous IV monitoring in addition to the subjective "Touch, Look, Compare"— and severe infiltration injuries dropped 93.3% (4.9% → 1.1%).

🔗 Read the full blog: https://www.ivwatch.com/2025/08/14/how-continuous-iv-surveillance-technology-is-transforming-neonatal-iv-care/

Powerful Clinical Evidence: Continuous IV Monitoring Reduces Severe NICU InjuriesIn neonatal care, even the smallest IV ...
12/29/2025

Powerful Clinical Evidence: Continuous IV Monitoring Reduces Severe NICU Injuries

In neonatal care, even the smallest IV can cause serious problems. A new BMJ Open study highlights how early detection technology can help prevent serious peripheral IV infiltrations and extravasations (PIVIEs) in the most vulnerable patients.

PIVIEs are the most common neonatal IV complication and often develop silently, causing significant harm before they are noticed.

Roland VanRens analyzed data from a major NICU in Doha, Qatar, where clinicians compared traditional “Touch, Look, Compare” checks with ivWatch continuous IV monitoring in addition to the subjective "Touch, Look, Compare"— and severe infiltration injuries dropped 93.3% (4.9% → 1.1%).

🔗 Read the full blog: https://lnkd.in/d2naQHxe

As we celebrate the holidays and reflect on an incredible year, one thing unites everyone at ivWatch: improving patient ...
12/24/2025

As we celebrate the holidays and reflect on an incredible year, one thing unites everyone at ivWatch: improving patient safety, its what we wake up for every morning.

Every day, we tackle new challenges as a team, because IV harm is often hidden and demands better. This work isn’t just about an idea or technology—it’s about shaping a future where ivWatch sets the new standard of patient care.

Each obstacle we surpass new milestones, each advancement gets us closer to a world where clinicians have the tools to prevent infiltration injuries before they become serious. That mission drives us every day.

What Every Patient Should Know Before Getting An IV.Did you know that up to 80–90% of patients in a hospital will receiv...
12/23/2025

What Every Patient Should Know Before Getting An IV.

Did you know that up to 80–90% of patients in a hospital will receive an intravenous (IV) line at some point during their stay¹? These lines deliver fluids, medications, and nutrients directly into your bloodstream.

As common as IVs are, many patients don’t realize there can be hidden risks. If the fluid meant for your vein leaks into surrounding tissue — a problem called infiltration or extravasation — it can lead to pain, swelling, and other complications.

3 patient-powered tips:
• Ask Questions – Know what fluid is being infused and the experience level of who is inserting your IV.
• Speak Up – IVs should NOT hurt. If you experience pain, swelling, or leaking? Tell your care team immediately.
• Monitor After Removal – Often IV injuries evolve over time be sure to watch the insertion site for redness or swelling as it could signal infection or an extravasation injury.

IV complications can be serious—early detection matters.

Learn more: https://www.ivwatch.com/2020/05/27/techniques-to-prepare-and-care-for-an-iv/

¹ 𝘙𝘪𝘤𝘬𝘢𝘳𝘥 𝘊𝘔, 𝘞𝘦𝘣𝘴𝘵𝘦𝘳 𝘑, 𝘞𝘢𝘭𝘭𝘪𝘴 𝘔𝘊, 𝘦𝘵 𝘢𝘭. 𝘗𝘦𝘳𝘪𝘱𝘩𝘦𝘳𝘢𝘭 𝘪𝘯𝘵𝘳𝘢𝘷𝘦𝘯𝘰𝘶𝘴 𝘤𝘢𝘵𝘩𝘦𝘵𝘦𝘳 𝘤𝘰𝘮𝘱𝘭𝘪𝘤𝘢𝘵𝘪𝘰𝘯𝘴 𝘪𝘯 𝘢𝘥𝘶𝘭𝘵𝘴: 𝘈 𝘮𝘶𝘭𝘵𝘪𝘤𝘦𝘯𝘵𝘳𝘦 𝘤𝘰𝘩𝘰𝘳𝘵 𝘴𝘵𝘶𝘥𝘺. 𝘉𝘔𝘑 𝘖𝘱𝘦𝘯.

We’re introducing a new clinical education tool designed to shed light on one of the most underreported—and often hidden...
12/22/2025

We’re introducing a new clinical education tool designed to shed light on one of the most underreported—and often hidden—patient harms in healthcare.

While starting a peripheral IV is routine, infiltration and extravasation injuries occur more frequently than many realize and can lead to serious consequences, including tissue damage, medication errors, and even amputation.

Experience alone does not eliminate risk. Traditional indicators such as blood return and an easy saline flush can be misleading and are no longer reliable safeguards. This new visual resource reveals the underlying causes of IV failure and highlights the hidden progression of infiltration and extravasation, reinforcing the importance of proactive assessment and earlier detection.

Don’t wait for harm to make the risk visible. Educate yourself, share this resource, and help advance safer IV care.

Watch here: https://www.ivwatch.com/2025/12/18/understanding-iv-infiltration-and-extravasation-a-new-educational-resource-for-clinicians/

Not all IV drugs carry the same risk — but all infiltrations can cause harm.Red/Yellow/Green (RYG) and Red/Amber/Green (...
12/18/2025

Not all IV drugs carry the same risk — but all infiltrations can cause harm.

Red/Yellow/Green (RYG) and Red/Amber/Green (RAG) frameworks classify IV medications by potential tissue injury, helping clinicians understand which drugs can cause severe damage, anticipate complications, and adjust monitoring or access routes accordingly. Knowing the category guides safer practice and faster intervention.

Even “low-risk” drugs can become dangerous if unnoticed. Continuous IV monitoring ensures early detection, giving clinicians the edge to prevent harm before it starts.

Read the full guide: https://www.ivwatch.com/2025/11/17/navigating-iv-drug-risks-a-guide-to-infiltration-and-extravasation-mitigation/

Peripheral IV infiltration and extravasation injuries (PIVIEs) are a global patient safety crisis—and one we are confron...
12/17/2025

Peripheral IV infiltration and extravasation injuries (PIVIEs) are a global patient safety crisis—and one we are confronting head-on.

ivWatch is partnering with forward-thinking distributors and hospitals around the world that recognize the urgency of this problem and are committed to taking proactive, meaningful action to strengthen IV therapy practices and reduce preventable patient harm.

Learn more about the causes of IV extravasations: https://www.ivwatch.com/2025/01/16/ivs-fail-too-often/

Calcium chloride 10% saves lives—but a small leak can destroy tissue in seconds.Used in emergencies for severe hypocalce...
12/16/2025

Calcium chloride 10% saves lives—but a small leak can destroy tissue in seconds.

Used in emergencies for severe hypocalcemia, hyperkalemia, and calcium channel blocker overdose, an extravasation can cause cell death, necrosis, and even amputation.

Prevented with proactive protocols, vigilant monitoring, and rapid intervention, these injuries highlight the need for safe infusion practices and teamwork.

Strengthen IV safety and patient protection—learn more about calcium chloride infiltrations : https://www.ivwatch.com/2025/11/04/the-hidden-hazard-understanding-calcium-chloride-10-extravasation-and-its-risks/


12/15/2025

IV Safety is where real leadership shows up.

When hospitals move beyond “standard practice” and commit to continuous IV monitoring, they’re making a clear statement: preventable harm is no longer acceptable. Visual checks alone miss the earliest signs of infiltration.

Continuous monitoring changes that. It equips nurses with real-time data so they can catch complications before they escalate. It reduces avoidable injuries, supports clinical workflow, and raises the level of safety for every patient, every infusion.

Hospitals that lead on IV safety aren’t just adopting new technology — they’re redefining what accountable, proactive, patient-centered care looks like. This mentality is embedded into institutional culture.

Paul Kempinski, MS, FACHE, CEC

IVSafety

Clinicians: Stop leaving IV safety to chance. Start relying on math and science for predictable results and injury sever...
12/10/2025

Clinicians: Stop leaving IV safety to chance. Start relying on math and science for predictable results and injury severity reduction.

Peripheral IV infiltrations happen every day—and the consequences can be life-altering. Periodic checks and subjective assessments like Touch, Look, Compare (TLC) aren’t enough. Patients deserve more than a quick look and a hopeful flush.

ivWatch is the only proven technology delivering continuous, objective IV site monitoring:
•Detect infiltrations early—before injury occurs
•Reduce preventable harm, liability, and clinician burden
•Trusted across leading hospitals worldwide

This isn’t just innovation.
This is a fundamental non-negotiable shift in patient safety.

Download the White Paper:https://ivwatch.com/wp-content/uploads/2025/08/SmartTouch-White-Paper-DM-1002098.pdf

This is what happened to Barby Ingle. Her anesthesia wasn’t fully reaching her vein, and the only reason the team knew s...
12/09/2025

This is what happened to Barby Ingle. Her anesthesia wasn’t fully reaching her vein, and the only reason the team knew something was wrong? Tears were streaming down her face.

IV infiltrations aren’t just uncomfortable—they can be dangerous and traumatic, especially when critical medications are involved. Many infiltrations go unnoticed until it’s too late.

Continuous IV monitoring with ivWatch can detect leaks before visible signs appear, helping clinicians intervene early, prevent complications, and protect patients like Barby.

Read Barby's story here: https://www.ivwatch.com/2025/03/11/imagine-waking-up-during-surgery/

Every innovation at ivWatch is driven by a single goal: preventing avoidable harm and giving patients peace of mind. Our...
12/04/2025

Every innovation at ivWatch is driven by a single goal: preventing avoidable harm and giving patients peace of mind. Our team works on a true cause, knowing that advanced IV monitoring can prevent unnecessary pain, complications, and financial burden for vulnerable patients.

By pushing the boundaries of continuous IV site monitoring technology and collaborating closely with clinicians, we transform routine IV care into a safer, smarter, and a more reliable experience for patients everywhere. We help eliminate the risk.

Learn more about our company and the mission we stand by.
https://www.ivwatch.com/

Address

700 Tech Center Parkway, Suite 300
Newport News, VA
23606

Opening Hours

Monday 8:30am - 6pm
Tuesday 8:30am - 6pm
Wednesday 8:30am - 6pm
Thursday 8:30am - 6pm
Friday 8:30am - 6pm

Website

Alerts

Be the first to know and let us send you an email when ivWatch, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ivWatch, LLC:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

ivWatch, LLC is a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy. IV therapy is a basic yet critical component of care in hospital and outpatient settings, but it has a high failure rate. Continuous monitors exist to keep track of patients’ heart, blood oxygen levels and pulse rates. Until now, no technology has been available to continuously monitor the health of a patient’s IV site, and whether drugs or fluids are being delivered through the vein or leaking into the tissue. The ivWatch Model 400 is a FDA-cleared device to help clinicians monitor the status of a patient’s IV to aid in the early detection of peripheral IV infiltrations and extravasations. Through the use of non-invasive sensor technology, the ivWatch Model 400 can help reduce potentially serious medication dosing errors and associated patient harm from infiltration events. A continuously monitored peripheral IV also offers an alternative to more intrusive vascular access devices when medically indicated. Use of these devices has increased, but can also pose significant risk of harm to patients and greater cost and liability for hospitals. ivWatch has the potential to transform IV therapy by improving patient care and safety, and offering health care providers a much-needed, reliable and cost-effective solution for continuously monitoring peripheral IVs.